Implementation and Impact of HAV and HBV Vaccination Programs in South America-Reference-Cited by-同舟云学术

Implementation and Impact of HAV and HBV Vaccination Programs in South America

Published:2013-09-26 Issue:4 Volume:12 Page:305-311
ISSN:1540-3416
Container-title:Current Hepatitis Reports
language:en
Short-container-title:Curr Hepatitis Rep

Author:

Paraná Raymundo,Schinoni Maria Isabel

Publisher

Springer Science and Business Media LLC

Subject

Virology,Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s11901-013-0186-2.pdf

Reference65 articles.

1. Paraná R, Almeida D. HBV Epidemiology in Latin America. J Clin Virol. 2005;34(Suppl1):S130–3.

2. Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol. 2012;55:296–302.

3. Shouval D, Hepatitis A. The inmunological basis for immunization series. Module 18 Geneva WHO. 2011;18:1–50.

4. • World Health Organization (WHO), Inmunization Vacines and Bilogical, Hepatitis B last updated 12 July 2012. Available at http://www.who.int/immunization/topics/hepatitis _b/en/index.htlm . Accessed at June 2013. Article about first data and last data of hepatitis A and B prevalence and vaccination in South America.

5. World Health Organization. Department of Communicable Disease Surveillance and Response.WHO/CDS/CSR/EDC/2000.7 Available at http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf accessed at june 2013.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociodemographic and spatiotemporal profiles of hepatitis-A in the state of Pará, Brazil, based on reported notified cases;Geospatial Health;2021-11-03

2. Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil;PLOS ONE;2018-09-07